ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/Pharmaceutical Intermediate/N-nitroso-lisinopril
C21H30N4O6
434.5 g/mol
Pharmaceutical Intermediate

N-nitroso-lisinopril

CAS519175-80-5
Category
Pharmaceutical Intermediate
Compound Class
Peptide
Primary Use
Pharmaceutical Intermediate

N-nitroso-lisinopril is a nitrosamine impurity of lisinopril, an angiotensin-converting enzyme inhibitor used in pharmaceutical manufacturing. It is primarily employed as a reference standard or research compound for impurity profiling and quality control in drug development.

reference standard for nitrosamine impurity testingresearch compound for pharmaceutical quality control

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing N-nitroso-lisinopril?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

ReferenceSame Category

Ethyl 4-iodobenzoate

CAS51934-41-9

pharmaceutical intermediate

ReferenceSame Category

Chromane-2-carboxylic acid

CAS51939-71-0

pharmaceutical intermediate

ReferenceSame Category

2-Methylpyrimidine-5-carboxylic acid

CAS5194-32-1

pharmaceutical intermediate

ReferenceSame Category

4-oxiranylmethoxy-9H-carbazole

CAS51997-51-4

pharmaceutical intermediate

Referencesame scaffold

Lisinopril

CAS76547-98-3

pharmaceutical raw material

Referencesame scaffold

Lisinopril dihydrate

CAS83915-83-7

pharmaceutical raw material

Referencesame scaffold

N-nitroso-enalapril

CAS2994317-06-3

pharmaceutical intermediate

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more
Identifiers
IUPAC Name

(2S)-1-[(2S)-6-amino-2-[[(1S)-1-carboxy-3-phenylpropyl]-nitrosoamino]hexanoyl]pyrrolidine-2-carboxylic acid

InChIKey

WLZGMQJZWKPZQR-BZSNNMDCSA-N

SMILES

C1C[C@H](N(C1)C(=O)[C@H](CCCCN)N([C@@H](CCC2=CC=CC=C2)C(=O)O)N=O)C(=O)O

Synonyms (4)
  • N-nitroso-lisinopril

Sourcing N-nitroso-lisinopril?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→